| abstract |
IT REFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES FESOTERODINE AND A STABILIZER SELECTED AMONG XYLITOL, SORBITOL, POLYDEXTROSE, ISOMALT, AMONG OTHERS, WHERE THE FESOTHERODINE / STABILIZER RATIO IS 1% -20% p / p / 20%. THE COMPOSITION IS OBTAINED THROUGH A WET GRANULATION METHOD AND HAS DELAYED RELEASE AGENTS TO CELLULOSE OR HYDROXYPROPYLMETILCELLULOSE ETHER OR ESTER. SUCH COMPOSITION IS USEFUL IN THE TREATMENT OF URINARY TRACT DYSFUNCTIONS, SUCH AS OVERACTIVE BLADDER AND URINARY INCONTINENCE |